US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...
LOS ANGELES, CA - January 08, 2026 - PRESSADVANTAGE - Confidein is introducing a nationwide initiative that reimagines ...
A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...
A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...
Long Island acupuncture clinic expands services with AcuNova Acupuncture, a specialized approach designed to support ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
The proposed charter public high school would fill a gap in the state’s Career and Technical Education landscape, writes one ...
Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker ...
Veterans often step into ownership already equipped with the leadership toolkit many entrepreneurs spend years developing.
Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results